Activation of nuclear factor-κB contributes to growth and aggressiveness of papillary thyroid carcinoma.
about
Signaling Pathways in Thyroid Cancer and Their Therapeutic ImplicationsTargeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid CancerDiosgenin relieves goiter via the inhibition of thyrocyte proliferation in a mouse model of Graves' disease.Protocol of a thyroid cancer longitudinal study (T-CALOS): a prospective, clinical and epidemiological study in KoreaFOXC1 promotes melanoma by activating MST1R/PI3K/AKT.The association between BRAF (V600E) mutation and pathological features in PTC.BRAF Immunohistochemistry Using Clone VE1 is Strongly Concordant with BRAF(V600E) Mutation Test in Papillary Thyroid Carcinoma.MUC2 Expression Is Correlated with Tumor Differentiation and Inhibits Tumor Invasion in Gastric Carcinomas: A Systematic Review and Meta-analysis.Diagnostic Accuracy of BRAF Immunohistochemistry in Colorectal Cancer: a Meta-Analysis and Diagnostic Test Accuracy Review.Targeted next generation sequencing identifies somatic mutations and gene fusions in papillary thyroid carcinoma.BRAFV600E and RET/PTC Promote Proliferation and Migration of Papillary Thyroid Carcinoma Cells In Vitro by Regulating Nuclear Factor-κB.Characteristics of neck level VI lymph nodes in papillary thyroid carcinoma: correlation between nodal characteristics and primary tumor.Melatonin suppresses thyroid cancer growth and overcomes radioresistance via inhibition of p65 phosphorylation and induction of ROS.BRAF V600E and RET/PTC Promote the Activity of Nuclear Factor-κB, Inflammatory Mediators, and Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Study of 50 Patients in Inner MongoliaThe Role of the Transcription Factor Nuclear Factor-kappa B in Thyroid Autoimmunity and Cancer
P2860
Q26764899-C1F54697-50AA-4FDE-B8DE-803F371B8A7EQ28547158-521F34C4-F294-400F-BA13-29AACF98D2A1Q33823673-73543F18-F719-4E9B-9C91-2FB698099BD6Q34903411-255C3E32-86D4-421F-824F-BD67D7F79CCBQ37708952-41257A2A-131A-4BCA-836A-6A2310BAFCBBQ38175816-68F04AB7-F28D-47A3-BC13-F4CB3F4EDF4CQ38469155-1A78BA10-DD04-4EE1-8502-60C9776158E6Q38505089-5A064A96-3443-47A1-8CE1-B4E2C58C70D6Q38838631-6B1C9D76-7FEF-4F5A-A5E3-17FA875333AEQ41233717-35CEF255-5CEA-432A-9668-E6708A883BAAQ47106475-306F2E49-8F88-432D-A6CB-D335A54C3E0FQ53649509-A4BF63FD-EA14-4CB5-B6FB-FDBE837AF8EDQ54258517-EEC2576E-13D1-4237-8F7D-29210476946CQ58693775-7CED3474-DC60-49D2-8881-3F2DD759C2DEQ58729438-901FD4D3-EAA8-4FA4-B213-32E8CFD68333
P2860
Activation of nuclear factor-κB contributes to growth and aggressiveness of papillary thyroid carcinoma.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Activation of nuclear factor-κ ...... f papillary thyroid carcinoma.
@ast
Activation of nuclear factor-κ ...... f papillary thyroid carcinoma.
@en
Activation of nuclear factor-κ ...... f papillary thyroid carcinoma.
@nl
type
label
Activation of nuclear factor-κ ...... f papillary thyroid carcinoma.
@ast
Activation of nuclear factor-κ ...... f papillary thyroid carcinoma.
@en
Activation of nuclear factor-κ ...... f papillary thyroid carcinoma.
@nl
prefLabel
Activation of nuclear factor-κ ...... f papillary thyroid carcinoma.
@ast
Activation of nuclear factor-κ ...... f papillary thyroid carcinoma.
@en
Activation of nuclear factor-κ ...... f papillary thyroid carcinoma.
@nl
P2093
P1476
Activation of nuclear factor-κ ...... f papillary thyroid carcinoma.
@en
P2093
Chanheun Park
Dong Hoon Kim
Guhyun Kang
Hyun Joo Lee
Jin Hee Sohn
Joo Heon Kim
Jung-Soo Pyo
Kyungeun Kim
Seoung Wan Chae
Sung-Im Do
P304
P356
10.1016/J.PRP.2013.02.004
P577
2013-03-05T00:00:00Z